A synthetic neuropeptide studied for its role in neuroendocrine signaling and central nervous system regulation. Research focus includes its interaction with hypothalamic pathways, stress-response mechanisms, and GABA-related signaling. For research use only. Not for human consumption.
DSIP (Delta Sleep–Inducing Peptide) is a synthetic research neuropeptide composed of a short amino acid sequence commonly described in the literature as an octa-/nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu). Since its initial identification, DSIP has been investigated in experimental models focused on neuroendocrine signaling and central nervous system regulation.
Published research has explored DSIP’s interaction with hypothalamic pathways, stress-response mechanisms, and inhibitory neurotransmitter systems, including GABA-related signaling. Its molecular structure and central activity profile have made DSIP a useful subject for studies examining sleep-associated signaling, circadian rhythm regulation, and adaptive neurobiological responses under controlled laboratory conditions.
Because of its defined sequence and documented biological relevance, DSIP continues to serve as a research tool in peptide neurobiology and neuroendocrine system investigations.
For research use only. Not for human consumption.
References
Schoenenberger GA, et al. Proceedings of the National Academy of Sciences USA. 1977;74(9):4025–4029.
Graf MV, et al. Neuropeptides. 1984;4(3):225–238.
Antonijevic I, et al. Journal of Neuroendocrinology. 1992;4(4):431–439.